BIOG-B:STO
BioGaia AB
127,30 SEK
arrow_downward
-1,55%(-2,00) 1G
23 ott, 16:29:54 GMT+1 · SEK
search
Tutti i simboli
| Simbolo | Prezzo | Cambio | % di cambio |
|---|
insights_autoGenerazione degli insight principali per BIOG-B in corso…
Apertura
128,00 SEK
Massimo
128,50 SEK
Minimo
124,30 SEK
Cap. mercato
12,54 Mld
Vol. medio
180,90K
Volume
0,00
Max 52 sett.
136,30 SEK
Min 52 sett.
96,20 SEK
Azioni in circolazione
98,50 Mln
N. di dipendenti
251
Apertura
128,00 SEK
Massimo
128,50 SEK
Minimo
124,30 SEK
Cap. mercato
12,54 Mld
Vol. medio
180,90K
Volume
0,00
Max 52 sett.
136,30 SEK
Min 52 sett.
96,20 SEK
Azioni in circolazione
98,50 Mln
N. di dipendenti
251
Articoli giornalistici
Da fonti web e partner giornalistici
www.marketscreener.com
·
2 giorni fa
Transcript : BioGaia AB, Q3 2026 Earnings Call, Oct 22, 2026
Investing.com Australia
·
2 giorni fa
Earnings call transcript: BioGaia tops Q3 with 67% EPS growth, stock rises
TradingView
·
2 giorni fa
BioGaia Q3 2026 Earnings Call Is Live
Profilo
BioGaia is a Swedish biotechnology company that develops, markets and sells a range of probiotic products. It has patented the use of several Lactobacillus reuteri strains and offers gut and immune health products containing L. reuteri Protectis. Their oral health products contain L. reuteri Prodentis, a blend of the L. reuteri strains DSM 17938 and ATCC PTA 5289. Products containing L. reuteri have been proven to be both effective and safe in several applications: infant colic, diarrhea prevention and mitigation in children, eradication of H. pylori infection and reduction of side effects from standard H. pylori treatment, amelioration of gingivitis, and general illness prevention in children and adults. BioGaia was ranked 9th in the Top 30 Global Probiotic Food Ingredient Companies list by FoodTalks in 2021. The BioGaia -B share is listed on the NASDAQ OMX Nordic Exchange. Wikipedia
Informazioni su BioGaia AB